Eflornithine (hydrochloride, hydrate) structure
|
Common Name | Eflornithine (hydrochloride, hydrate) | ||
---|---|---|---|---|
CAS Number | 96020-91-6 | Molecular Weight | 236.64500 | |
Density | 1.293g/cm3 | Boiling Point | 347ºC at 760mmHg | |
Molecular Formula | C6H15ClF2N2O3 | Melting Point | >210ºC (dec.) | |
MSDS | N/A | Flash Point | 163.7ºC |
Use of Eflornithine (hydrochloride, hydrate)Eflornithine hydrochloride, hydrate is a specific, irreversible inhibitor of the enzyme ornithine decarboxylase. Eflornithine is a medication for the treatment of African trypanosomiasis and excessive facial hair growth in women. |
Name | DL-α-Difluoromethylornithine Hydrochloride Monohydrate |
---|---|
Synonym | More Synonyms |
Description | Eflornithine hydrochloride, hydrate is a specific, irreversible inhibitor of the enzyme ornithine decarboxylase. Eflornithine is a medication for the treatment of African trypanosomiasis and excessive facial hair growth in women. |
---|---|
Related Catalog | |
In Vivo | Eflornithine is the only new molecule registered for the treatment of human African trypanosomiasis over the last 50 years. It is the drug used mainly as a back-up for melarsoprol refractory Trypanosoma brucei gambiense cases[1]. In subjects with excessive, unwanted facial hair, eflornithine 15% cream is superior to placebo in reducing hair growth. After 24 weeks' treatment, 58% of eflornithine and 34% of placebo subjects have at least some improvement in facial hirsutism[2]. The hair growth inhibitory activity of eflornithine is significantly enhanced when the eflornithine cream is applied onto a mouse skin area pretreated with microneedles[3]. Treatment of coarctation hypertensive rats with eflornithine results in a normalization of the contractile intensity to KCI and norepinephrine and relaxations to acetylcholine by 14 days of hypertension[4]. |
Animal Admin | Mice: The skin area where the hair is removed is then treated with the eflornithine hydrochloride 13.9% cream (-50 mg per mouse per treatment) using a spatula 2 times a day in an interval of at least 8 h for a maximum period of 36 days[3]. |
References |
[2]. Balfour JA, et al. Topical eflornithine. Am J Clin Dermatol. 2001;2(3):197-201; discussion 202. |
Density | 1.293g/cm3 |
---|---|
Boiling Point | 347ºC at 760mmHg |
Melting Point | >210ºC (dec.) |
Molecular Formula | C6H15ClF2N2O3 |
Molecular Weight | 236.64500 |
Flash Point | 163.7ºC |
Exact Mass | 236.07400 |
PSA | 98.57000 |
LogP | 1.91080 |
Storage condition | 2~8°C |
HS Code | 2922499990 |
---|
HS Code | 2922499990 |
---|---|
Summary | HS:2922499990 other amino-acids, other than those containing more than one kind of oxygen function, and their esters; salts thereof VAT:17.0% Tax rebate rate:9.0% Supervision conditions:AB(certificate of inspection for goods inward,certificate of inspection for goods outward) MFN tariff:6.5% General tariff:30.0% |
2,5-diamino-2-(difluoromethyl)pentanoic acid,hydrate,hydrochloride |
Eflornithine (hydrochloride, hydrate) |